Cargando…

The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis

BACKGROUND: Immune-related adverse events (irAEs) are common during immune checkpoint inhibitor (ICI) treatment and reported to be associated with good survival. This study evaluated the association between onset timing of irAEs and survival of cancer patients treated with ICIs. METHODS: Databases i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Huilin, Xu, Ximing, Ge, Wei, Lei, Jinju, Cao, Dedong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758867/ https://www.ncbi.nlm.nih.gov/pubmed/33425028 http://dx.doi.org/10.1177/1758835920980546

Ejemplares similares

A Systematic Review and Meta-Analysis of Immune-Related Adverse Events of Anti-PD-1 Drugs in Randomized Controlled Trials
por: Wang, Yukun, et al.
Publicado: (2020)

Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
por: Nso, Nso, et al.
Publicado: (2020)

Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
por: Pei, Wen-Guang, et al.
Publicado: (2023)

Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC
por: Zhu, Qian, et al.
Publicado: (2017)

Adverse Events Related to Tirzepatide
por: Mishra, Rahul, et al.
Publicado: (2023)

Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
por: Xu, Wentao, et al.
Publicado: (2023)

Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis
por: Wang, Hao, et al.
Publicado: (2021)

The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2019)

Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2021)

Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)

Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events
por: Mashiana, Harmeet Singh, et al.
Publicado: (2018)

Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis
por: Jiang, Wen, et al.
Publicado: (2017)

Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2020)

Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis
por: Ruan, Haihua, et al.
Publicado: (2017)

Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis
por: Qian, Wenwei, et al.
Publicado: (2021)

FHIT down-regulation was inversely linked to aggressive behaviors and adverse prognosis of gastric cancer: a meta- and bioinformatics analysis
por: Zheng, Hua-Chuan, et al.
Publicado: (2017)

Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer
por: Li, Fei, et al.
Publicado: (2017)

LncRNA NORAD as a Novel Predictor of Lymph Node Metastasis and Prognosis in Solid Tumors: A Systematic Review and Meta-Analysis
por: Ye, Tao, et al.
Publicado: (2020)

Prognostic role of DEK in human solid tumors: a meta-analysis
por: Liu, Gang, et al.
Publicado: (2017)

Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis
por: Zhong, Jie-Hui, et al.
Publicado: (2017)

Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis
por: Rizzo, Alessandro, et al.
Publicado: (2020)

The prognostic value of p62 in solid tumor patients: a meta-analysis
por: Ruan, Haihua, et al.
Publicado: (2017)

The prognostic value of NRF2 in solid tumor patients: a meta-analysis
por: Wang, Lingling, et al.
Publicado: (2017)

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
por: Cao, Jing, et al.
Publicado: (2019)

The effect of pathological fractures on the prognosis of patients with osteosarcoma: a meta-analysis of 14 studies
por: Zhou, Yifei, et al.
Publicado: (2017)

Intensified Antiplatelet Treatment Reduces Major Cardiac Events in Patients with Clopidogrel Low Response: A Meta-analysis of Randomized Controlled Trials
por: Xu, Lei, et al.
Publicado: (2016)

Adoptive immunotherapy shows encouraging benefit on non-small cell lung cancer: a systematic review and meta-analysis
por: Zhao, Binghao, et al.
Publicado: (2017)

The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis
por: Cao, De-Dong, et al.
Publicado: (2017)

Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
por: Zhao, Bin, et al.
Publicado: (2020)

CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis
por: Li, Hongru, et al.
Publicado: (2017)

Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis
por: Zhang, Xianyun, et al.
Publicado: (2017)

Does a coaxial double pigtail stent reduce adverse events after lumen apposing metal stent placement for pancreatic fluid collections? A systematic review and meta-analysis
por: Giri, Suprabhat, et al.
Publicado: (2023)

Predicting STAT1 as a prognostic marker in patients with solid cancer
por: Zhang, Jinguo, et al.
Publicado: (2020)

The expression of circRNAs as a promising biomarker in the diagnosis and prognosis of human cancers: a systematic review and meta-analysis
por: Ding, Han-Xi, et al.
Publicado: (2017)

Treatment-related toxicities of apatinib in solid tumors: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2018)

The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis
por: Tang, Shihui, et al.
Publicado: (2017)

Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
por: Cao, Guangchao, et al.
Publicado: (2015)

Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2017)

Serum cross-linked N-telopeptide of type I collagen for the diagnosis of bone metastases from solid tumours in the Chinese population: Meta-analysis
por: Zhang, Yudong, et al.
Publicado: (2016)

The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
por: Wang, Changwen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gl4gocjmkh1f8fj3lj43sk3e7c